மாக்னோலியா மருத்துவ தொழில்நுட்பங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மாக்னோலியா மருத்துவ தொழில்நுட்பங்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மாக்னோலியா மருத்துவ தொழில்நுட்பங்கள் Today - Breaking & Trending Today

Sepsis Testing Accuracy Technology Enables Enhanced Patient Safety, Experience and Satisfaction

Sepsis Testing Accuracy Technology Enables Enhanced Patient Safety, Experience and Satisfaction
Steripath can eliminate unnecessary venipunctures by enabling blood culture draws from peripheral IV starts
News provided by
Share this article
®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination,
1 announced today continued clinical efficacy data supporting multiple, peer-reviewed clinical studies that confirm zero or near-zero false-positive rates from blood cultures drawn from peripheral intravenous (PIV) starts. These data signify that patient harm from avoidable venipunctures and sepsis misdiagnosis can be prevented.
Sepsis is a complex and aggressive syndrome impacting at least 1.7 million people in the U.S. annually of which nearly 270,000 die. ....

Mary Bell , Richard Patton , Greg Bullington , Clinical Laboratories At University Of Washington Medicine , Magnolia Medical Technologies Inc , Lee Health , Magnolia Medical Technologies , Magnolia Medical , Medical Director , Clinical Laboratories , Washington Medicine , Northwest Medical , Medical Technologies , Initial Specimen Diversion Technique , Emergency Nursing , மேரி மணி , ரிச்சர்ட் பாட்டன் , கிரெக் புல்லிங்டன் , மாக்னோலியா மருத்துவ தொழில்நுட்பங்கள் இன்க் , லீ ஆரோக்கியம் , மாக்னோலியா மருத்துவ தொழில்நுட்பங்கள் , மாக்னோலியா மருத்துவ , மருத்துவ இயக்குனர் , மருத்துவ ஆய்வகங்கள் , வாஷிங்டன் மருந்து , வடமேற்கு மருத்துவ ,

Magnolia Medical Joins Emergency Nurses Association's Corporate Engagement Council as Category-Exclusive Member

®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination
1, announced today that it has become a category-exclusive member of the Emergency Nurses Association (ENA
™) Corporate Engagement Council.
The ENA Corporate Engagement Council (CEC) is designed to support innovation, advances in emergency nursing education, research and advocacy. Together, Magnolia Medical leadership and ENA leaders from the association team, board of directors and key ENA influencers – a mix of businesses, educators and hospitals – will create new opportunities to educate the emergency nursing profession on the most recent advancements in blood culture best practices and sepsis testing accuracy.
We are thrilled to partner with the Emergency Nurses Association as an active member of its Corporate Engagement Council, said Greg Bullington, CEO of Magnolia Medical. We look forward to working closely with ENA leadership to further improve patien ....

Steripath Gen , Terrence Sykes , Greg Bullington , Emergency Nurses Association , Magnolia Medical Technologies Inc , Corporate Engagement Council , Stanford Health Care , Magnolia Medical Technologies , Corporate Engagement , Engagement Council , Magnolia Medical , Development Officer Terrence , Specimen Diversion Device , Practice Guideline , Steripath Micro , Eliminating Blood Culture Contamination , Medical Technologies , Initial Specimen Diversion Technique , Clinical Microbiology , Best Practice Guideline , Blood Culture Contamination , Emergency Nursing , Infectious Diseases , Hospital Infection , கிரெக் புல்லிங்டன் , அவசரம் செவிலியர்கள் சங்கம் ,

Magnolia Medical Launches New "Diverted" Multi-Media Advertising Campaign to Educate Healthcare Providers on Benefits of Steripath®

Share this article
Share this article
SEATTLE, April 14, 2021 /PRNewswire/ Magnolia Medical Technologies, Inc. recently launched a new multi-media advertising campaign to promote the benefits of the Steripath
® Initial Specimen Diversion Device
® (ISDD
®) platform.
Built around the theme Diverted , the campaign underscores the critical need for the use of Magnolia s ISDD, which diverts the initial 1.5-2.0 mL of blood while maintaining a vein-to-bottle closed system which reduces blood culture contamination rates and false-positive central line-associated bloodstream infections (CLABSI) to improve patient outcomes.
(PRNewsfoto/Magnolia Medical Technologies)
Diverted embraces bold new creative assets to support a multichannel media campaign that engages healthcare leadership as well as stakeholders within emergency departments, infection prevention, quality, laboratory and nursing. The creative is designed to educate these audiences on the ....

Magnolia Steripath Gen , Steripath Gen , Greg Bullington , Steripath Micro , Clinical Microbiology Reviews , Medical Technologies , Initial Specimen Diversion Technique , Initial Specimen Diversion , Emergency Nursing , Infectious Diseases , Magnolia Medical Technologies , கிரெக் புல்லிங்டன் , மருத்துவ நுண்ணுயிரியல் மதிப்புரைகள் , மருத்துவ தொழில்நுட்பங்கள் , ஆரம்ப மாதிரி திசை திருப்புதல் நுட்பம் , ஆரம்ப மாதிரி திசை திருப்புதல் , அவசரம் நர்சிங் , தொற்று நோய்கள் , மாக்னோலியா மருத்துவ தொழில்நுட்பங்கள் ,

Stanford Health Care Presents Unprecedented Study Results with Steripath Gen2 ISDD to Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria

®, the only FDA-cleared device platform indicated to reduce blood culture contamination
1 – today announced that unprecedented Steripath clinical study results were presented to the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB).
Lucy S. Tompkins, MD, Ph.D., a professor and infectious diseases, microbiology and epidemiology expert at Stanford Health Care, presented Steripath
® Gen2 Initial Specimen Diversion Device
® (ISDD
®) phase-one study results at the PACCARB meeting in Washington, DC demonstrating unmatched reductions to blood culture contamination and false-positive central line-associated bloodstream infection (CLABSI) rates.
What was even more clinically significant is that a 0.0% contamination rate and 0.0% false-positive CLABSI rate were maintained across over 11,000 blood cultures when Steripath was used throughout the course of the 10-month total trial period, continued Dr. Tompkins ....

Steripath Gen , Greg Bullington , Us Department Of Health , Human Services , Stanford Health Care , Eliminating Blood Culture Contamination , Specimen Diversion Device , Initial Specimen Diversion , Steripath Micro , Medical Technologies , Initial Specimen Diversion Technique , Emergency Nursing , Infectious Diseases , Clinical Microbiology , Hospital Infection , Magnolia Medical Technologies , கிரெக் புல்லிங்டன் , எங்களுக்கு துறை ஆஃப் ஆரோக்கியம் , மனிதன் சேவைகள் , ஸ்டான்போர்ட் ஆரோக்கியம் பராமரிப்பு , மாதிரி திசை திருப்புதல் சாதனம் , ஆரம்ப மாதிரி திசை திருப்புதல் , மருத்துவ தொழில்நுட்பங்கள் , ஆரம்ப மாதிரி திசை திருப்புதல் நுட்பம் , அவசரம் நர்சிங் , தொற்று நோய்கள் ,